Objective To investigate the clinical effect of ginger- partitioned moxibustion at Zusanli and Yongquan points combined with transarterial chemoembolization( TACE) in the treatment of primary liver cancer. Methods A total of 60 patients initially diagnosed with primary liver cancer with stagnation of liver qi and spleen deficiency who were hospitalized in The Affiliated Tumor Hospital of Guangxi Medical University from December 2013 to December 2014 were enrolled and randomly divided into moxibustion group and control group,with 30 patients in each group. The patients in both groups were given TACE and symptomatic / supportive treatment after TACE,including conventional liver- protecting,stomach- protecting,pain- relieving,and antiemetic treatment. The patients in the moxibustion group were given moxibustion since day 1 before TACE. Moxibustion was performed at bilateral Yongquan and Zusanli points once a day( 30 minutes each time) for 8 consecutive days. The patients' quality of life was recorded at 1 day before and 7 days after surgery,and the postoperative adverse events,traditional Chinese medicine( TCM) syndrome score,and EORTC QLQ- C30 results were compared between the two groups.The t- test was used for comparison of continuous data between groups,the chi- square test was used for comparison of categorical data between groups,and the Mann- Whitney U test was used for comparison of ranked data between groups. Results The moxibustion group had a significantly lower proportion of patients who experienced nausea and vomiting after surgery than the control group( Z = 9. 692,P =0. 046). Among the patients in the moxibustion group,7 achieved significant improvements in TCM syndrome and 16 achieved partial improvements in TCM syndrome,resulting in an overall response rate of 77%; among the patients in the control group,5 achieved significant improvements and 9 achieved partial improvements,resulting in an overall response rate of 47%; there was a significant difference in overall response rate between the two groups( χ~2= 7. 198,P = 0. 027). As for the quality of life,the moxibustion group had significantly better improvements in fatigue,anorexia,nausea / vomiting,and general health compared with the control group( t = 2. 722,2. 530,2. 538,and3. 144,P = 0. 011,0. 017,0. 017,and 0. 004). Conclusion Ginger- partitioned moxibustion at bilateral Zusanli and Yongquan points combined with TACE for the treatment of primary liver cancer can alleviate the adverse effects after TACE and improve patients' TCM syndrome and quality of life. This combined therapy reflects the features and advantages of “local and systemic”combined- modality therapy for primary liver cancer.
[1]SONG HX,QIAO F,SHAO M.Research advances in traditional Chinese medicine treatment for primary liver cancer[J].J Clin Hepatol,2016,32(1):174-177.(in Chinese)宋慧娴,乔飞,邵铭.中医药治疗原发性肝癌的研究进展[J].临床肝胆病杂志,2016,32(1):174-177.
|
[2]YANG LQ,QIN SK,GONG XL,et al.Clinical study on sorafenib for treating Chinese patients with advanced primary liver carcinoma[J].Chin J New Drugs,2013,22(17):2053-2059.(in Chinese)杨柳青,秦叔逵,龚新雷,等.索拉非尼治疗国人中晚期原发性肝癌的临床研究[J].中国新药杂志,2013,22(17):2053-2059.
|
[3]SHEN GW.Clinical effect of different acupuncture and moxibustion methods in prevention and treatment of toxic or side effects of chemotherapy[J].J Clin Med Pract,2010,14(9):57-59.(in Chinese)沈国伟.不同针灸方法防治化疗毒副反应的临床研究[J].实用临床医药杂志,2010,14(9):57-59.
|
[4]LEI HY.Effect of festering moxibustion therepy on zusanli on blood test of cancer patients[J].J Liaoning Univ Tradit Chin Med,2010,12(1):156-157.(in Chinese)雷海燕.足三里化脓灸对恶性肿瘤患者血象的影响[J].辽宁中医药大学学报,2010,12(1):156-157.
|
[5]WAN DS.Clinical oncology[M].3rd ed.Beijing:Science Press,2010.(in Chinese)万德森.临床肿瘤学[M].3版.北京:科学出版社,2010.
|
[6] SHI XM.Acupuncture and moxibustion science[M].2nd ed.Beijing:China Press of Traditional Chinese Medicine,2011:45-74,154-155.(in Chinese)石学敏.针灸学[M].2版.北京:中国中医药出版社,2011:45-74,154-155.
|
[7] Ministry of Health of the People's Republic of China.Guidelines for clinical research of Chinese medicine(Vol.3)[S].Beijing:Ministry of Health of the People's Republic of China,1997:3-36.(in Chinese)中华人民共和国卫生部.中药新药临床研究指导原则(第3辑)[S].北京:中华人民共和国卫生部,1997:3-36.
|
[8]LIANG HY,LU ZM.Current status and confusion in comprehensive interventional therapy for hepatocellular carcinoma[J].J Clin Hepatol,2016,32(1):44-48.(in Chinese)梁宏元,卢再鸣.原发性肝癌综合介入治疗现状与困惑[J].临床肝胆病杂志,2016,32(1):44-48.
|
[9] LI QW.Traditional Chinese medicine syndrome of primary liver cancer before and after chemoembolization[D].Beijing:Beijing Univ Chin Med,2005.(in Chinese)李泉旺.原发性肝癌化疗栓塞治疗前后中医症候学观察[D].北京:北京中医药大学,2005.
|
[10]XIANG J,CHEN G,OUYANG LZ,et al.Moxibustion treatment on gastric mucosal injury[J].Acta Chin Med,2016,31(218):1069-1072.(in Chinese)向娟,陈果,欧阳里知,等.艾灸治疗胃黏膜损伤研究述评[J].中医学报,2016,31(218):1069-1072.
|
[11]ZHANG J,WANG LL.Research advances in moxibustion in treatment of common side effects of chemotherapy[J].World J Integr Tradit Western Med,2014,9(4):443-445.(in Chinese)张静,王玲玲.艾灸治疗化疗常见副反应的研究进展[J].世界中西医结合杂志,2014,9(4):443-445.
|
[12]XU SA,YANG J,ZHAO BX.Possible therapeutic effect of ginger-partitioned moxibustion on chemotherapy induced toxic side effects and quality of life scale:a clinical observation[J].Global Tradit Chin Med,2014,7(12):901-905.(in Chinese)徐颂安,杨佳,赵百孝.隔姜灸对化疗期毒副反应及生存质量影响的临床观察[J].环球中医药,2014,7(12):901-905.
|
[13]LIU P,PAN XJ,HAN L,et al.Effects of long-term intervention of moxa smoke on T lymphocyte subsets and CD4+CD25+Treg in peripheral blood of Wistar rats[J].Chin Acupunct Moxibust,2013,33(2):145-148.(in Chinese)刘平,潘秀颉,韩丽,等.长期艾烟干预对Wistar大鼠外周血T淋巴细胞亚群及CD4+CD25+Treg的影响[J].中国针灸,2013,33(2):145-148.
|
[14]CHEN J,SONG GQ,YIN J,et al.Electroacupuncture improves impaired gastric motility and slow waves induced by rectal distension in dogs[J].Am J Physiol Gastrointest Liver Physiol,2008,295(3):g614-g620.
|
[15]ZHANG AL,CHEN RX,KANG MF,et al.Clinical effect of acupuncture and moxibustion in treatment of gastric motility disorder[J].Chin Acupunct Moxibust,1994,14(5):1-3.(in Chinese)张安莉,陈日新,康明非,等.针灸治疗胃动力障碍症临床疗效研究[J].中国针灸,1994,14(5):1-3.
|
[16] SHI YF.Thoughts on clinical effect evaluation of traditional Chinese medicine treatment for tumor[C]//The Proceedings of the National Academic Conference on Traditional Chinese Medicine Oncology in2013.Beijing:Oncology Branch of China Association of Chinese Medicine,2013:645.(in Chinese)施云福.中医肿瘤临床疗效评价思考[C]//2013年全国中医肿瘤学术年会论文集.北京:中华中医药学会肿瘤分会,2013:645.
|
[17]QIU M,LIU L,CHENG J,et al.A discussion of criteria for clinical effect evaluation of traditional Chinese medicine treatment for tumor[C]//The Proceedings of the 8th National Academic Forum on Integrated Traditional Chinese and Western Medicine for Young and Middle-aged Scholars.Zhengzhou:Youth Working Committee,China Society of Integrated Traditional Chinese and Western Medicine,2016:344-348.(in Chinese)邱敏,刘莉,程俊,等.中医肿瘤临床疗效评价标准建立探讨[C]//第八次全国中西医结合中青年学术论坛论文集.郑州:中国中西医结合学会青年工作委员会,2016:344-348.
|